Co-founders Eve Mcdavid & Dr. Onyinye Balogun

We are a Cervical Cancer innovation company.

We build inclusive products for people with a cervix and the providers who treat them. Learn more about our founders' story and vision to eradicate Cervical Cancer.

Our mission is to eradicate Cervical Cancer

Your cervix is a vital organ in your reproductive system and plays a crucial role in your overall well-being. Cervical Health is often affected by the Human Papillomavirus (HPV), the most common sexually transmitted infection (STI), that can cause Cervical Cancer and numerous other cancers that affect men and women. Though Cervical Cancer is preventable, treatable and curable, each year, over 600,000 women and persons with a cervix are diagnosed and more than 340,000 more will die preventable deaths.

At Mission-Driven Tech™, we develop solutions to normalize and modernize Cervical Health, a field that generates $26 in global economic value for every $1 invested.

Our vision is for a world without Cervical Cancer. We’re improving today’s standard of care so all women can safely access the cure: Brachytherapy.

Join us in the global movement to eradicate Cervical Cancer.

Our Products

Building the modern cure for Cervical Cancer.

We are developing a new, female-fitted brachytherapy medical device to improve procedure safety, patient outcomes and access to care.

About The Blossom

The Problem

Brachytherapy, powerful internal radiation procedures that cure Cervical Cancer, is administered with dated medical devices from the 1970s, before women's inclusion in clinical trials. These ill-fitting, rigid devices produce intolerable patient experiences, devastating side-effects and diminished patient outcomes.

Our Vision

Women & physicians deserve the safest treatment to cure cervical cancer. Brachytherapy devices should be designed to properly fit each woman's anatomy with insertion & removal ease, allowing physicians to administer safer, more effective treatment with improved physical, sexual & mental health outcomes.

The Solution

We're designing an internationally-patented, female-fitted medical device that addresses common complications and reduces pain and trauma. The new device paired with supporting patient & provider curriculum will standardize care, improve outcomes and expand access to care.

TOUCH brings transparency to Brachytherapy.

Brachytherapy treatment abandonment rates are as high as 40% with the current medical device treatment technology used in procedures today. While we work hard on The Blossom, we’ve listened to our customers searching for new strategies to improve treatment completion and outcomes now.

Lack of informed consent and inconsistent pain management are key issues hindering optimal Brachytherapy patient outcomes.

TOUCH brings Transparency to Brachytherapy.

TOUCH makes it easy to access preparation, procedure and recovery best practices so everyone involved in Brachytherapy can optimally navigate treatment as a team.

Our Founders

Dr. Onyinye Balogun

Chief Medical Officer & Co-Founder
Dr. Balogun is a world-renowned Radiation Oncologist and Assistant Professor of Radiation Oncology at Weill Cornell Medicine who uses her rich clinical expertise to pave a new path forward in cervical cancer care.
Eve McDavid

Chief Executive Officer & Co-Founder
Eve is a former longtime Google executive, cervical cancer survivor and global public advocate who uses her professional background and lived experience to fight for change in Cervical Cancer care.